Stock DNA
Pharmaceuticals & Biotechnology
RON 818 Million ()
10.00
NA
3.73%
-999,999.00
16.52%
1.53
Revenue and Profits:
Net Sales:
95 Million
(Quarterly Results - Mar 2025)
Net Profit:
32 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
135.48%
0%
135.48%
6 Months
135.48%
0%
135.48%
1 Year
135.48%
0%
135.48%
2 Years
135.48%
0%
135.48%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Biofarm SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.34%
EBIT Growth (5y)
7.96%
EBIT to Interest (avg)
78.45
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0
Tax Ratio
12.35%
Dividend Payout Ratio
41.06%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.22%
ROE (avg)
17.81%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.59
EV to EBIT
6.68
EV to EBITDA
5.62
EV to Capital Employed
1.94
EV to Sales
1.95
PEG Ratio
0.55
Dividend Yield
3.88%
ROCE (Latest)
29.04%
ROE (Latest)
16.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
95.10
55.60
71.04%
Operating Profit (PBDIT) excl Other Income
41.20
3.70
1,013.51%
Interest
0.00
0.00
Exceptional Items
-0.00
0.00
Consolidate Net Profit
32.30
1.10
2,836.36%
Operating Profit Margin (Excl OI)
387.90%
-9.30%
39.72%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is 71.04% vs -38.22% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is 2,836.36% vs -96.49% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
286.80
280.30
2.32%
Operating Profit (PBDIT) excl Other Income
98.70
94.70
4.22%
Interest
0.00
0.00
Exceptional Items
-0.10
-0.30
66.67%
Consolidate Net Profit
74.40
77.00
-3.38%
Operating Profit Margin (Excl OI)
285.30%
286.10%
-0.08%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.32% vs 1.19% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -3.38% vs 8.60% in Dec 2023






